FDA approves generic Viagra, more men need to be aware of melanoma risk

On March 9, 2016, the U.S. Food and Drug Administration (FDA) approved the first generic version of Pfizer Inc.’s Viagra. Law360 reports that Teva Pharmaceutical Industries Ltd.’s abbreviated 25-, 50- and 100-milligram sildenafil citrate tablets were all approved and the company will have market exclusivity for the next 180 days. However, due to a 12-day bench trial in 2011 where Pfizer sued Teva to enforce its patent, the generic could not be sold until the patent expired in 2019 or until permitted by the licensing agreement. According to CBS News and RAPS.org Teva will begin selling the drug Dec. 11, 2017. RAPS.org ... Read More